Clinical Trial Update: This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, and preliminary effects of inhaled BAY1237592 in patients with pulmonary arterial hypertension and chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• BAY1237592

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 1 | Status: COMPLETED